78
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL PAPERS

Shedding Light on Blepharospasm: A Patient–Researcher Partnership Approach to Assessment of Photophobia and Impact on Activities of Daily Living

, MD, , MD, , MD, , CCRA & , MD, PhD
Pages 49-54 | Accepted 29 Jan 2007, Published online: 08 Jul 2009

REFERENCES

  • Faucett D. Essential blepharospasm. Ophthalmology, M Yanoff, J S Duker. Mosby, Philadelphia 2004; 695–697
  • Elston J S, Marsden C D, Grandas F, Quinn N P. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye 1988; 2: 435–439
  • Kraft S P, Lang A E. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. CMAJ 1988; 139: 837–844
  • Defazio G, Livrea P. Epidemiology of primary blepharospasm. Mov Disord 2002; 17: 7–12
  • Defazio G, Livrea P, De Salvia R, et al. Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 2001; 56: 1579–1581
  • Duffey P O, Butler A G, Hawthorne M R, Barnes M P. The epidemiology of the primary dystonias in the north of England. Advances in Neurology, 3: Dystonia, S Fahn, C D Marsden, M R De Long. Lippincott-Raven, Philadelphia 1998; 121–126
  • Nakashima K, Kusumi M, Inoue Y, Takahashi K. Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan. Mov Disord. 1995; 10: 440–443
  • Nutt J G, Muenter M D, Aronson A, Kurland L T, Melton L J, 3rd. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988; 3: 188–194
  • Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000; 247: 787–792
  • Aramideh M, Eekhof J L, Bour L J, et al. Electromyography and recovery of the blink reflex in involuntary eyelid closure: a comparative study. J Neurol Neurosurg Psychiatry 1995; 58: 692–698
  • Berardelli A, Rothwell J C, Day B L, Marsden C D. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985; 108: 593–608, (Pt 3)
  • Creel D J, Holds J B, Anderson R L. Auditory brain-stem responses in blepharospasm. Electroencephalogr Clin Neurophysiol 1993; 86: 138–140
  • Pauletti G, Berardelli A, Cruccu G, Agostino R, Manfredi M. Blink reflex and the masseter inhibitory reflex in patients with dystonia. Mov Disord 1993; 8: 495–500
  • Tolosa E, Montserrat L, Bayes A. Blink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis. Mov Disord 1988; 3: 61–69
  • Fine P G, Digre K B. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol 1995; 15: 90–94
  • McCann J D, Gauthier M, Morschbacher R, et al. A novel mechanism for benign essential blepharospasm. Ophthal Plast Reconstr Surg 1999; 15: 384–389
  • Adams W H, Digre K B, Patel B CK, Anderson R L, Warner J EA, Katz B J. The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol. 2006; 142: 82–87
  • Anderson R L, Patel B C, Holds J B, Jordan D R. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg 1998; 14: 305–317
  • Hallett M. Blepharospasm: recent advances. Neurology 2002; 59: 1306–1312
  • Jankovic J, Orman J. Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 1984; 16: 371–376
  • Müller J, Wissel J, Kemmler G, et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 2004; 75: 749–753
  • Grandas F, Elston J, Quinn N, Marsden C D. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988; 51: 767–772
  • Reimer J, Gilg K, Karow A, Esser J, Franke G H. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 2005; 111: 64–70
  • Hall T A, McGwin G, Jr., Searcey K, et al. Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch Ophthalmol 2006; 124: 116–119
  • Lindeboom R, De Haan R, Aramideh M, Speelman J D. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 1995; 10: 444–449
  • Grivet D, Robert P Y, Thuret G, et al. Assessment of blepharospasm surgery using an improved disability scale: study of 138 patients. Ophthal Plast Reconstr Surg. 2005; 21: 230–234
  • Tucha O, Naumann M, Berg D, Alders G L, Lange K W. Quality of life in patients with blepharospasm. Acta Neurol Scand 2001; 103: 49–52
  • Muller J, Kemmler G, Wissel J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol. 2002; 249: 842–846
  • Fahn S. Assessment of the primary dystonias. Quantification of Neurologic Deficit, T L Munsat. Butterworth, Stoneham, MA 1989; 241–270
  • Chapman K L, Bartley G B, Waller R R, Hodge D O. Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995. Ophthal Plast Reconstr Surg 1999; 15: 106–110
  • Vanagaite J, Pareja J A, Storen O, White L R, Sand T, Stovner L J. Light-induced discomfort and pain in migraine. Cephalalgia 1997; 17: 733–741
  • Stewart W F, Lipton R B, Celentano D D, Reed M L. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267: 64–69
  • Hilker R, Schischniaschvili M, Ghaemi M, Jacobs A, Rudolf J. Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 2001; 71: 193–199
  • Schoeters L, Schelfhout P, Roets G, et al. Partnership working between university researchers and self-advocacy organizations: ‘A way forward for inclusion?’ in England and ‘Fine feathers make a fine bird’ in Flanders. J Intellect Disabil. 2005; 9: 345–357
  • Macaulay A C, Commanda L E, Freeman W L, et al. Participatory research maximises community and lay involvement. North American Primary Care Research Group. BMJ 1999; 319: 774–778
  • CDC/ATSDR Committee on Community Engagement. Principles of Community Engagement. Part 3: Applying Principles to the Community Engagement Process. 1997, http://www.cdc.gov/phppo/ pce/index.htm
  • Baty B J, Kinney A Y, Ellis S M. Developing culturally sensitive cancer genetics communication aids for African Americans. Am J Med Genet A. 2003; 118: 146–155
  • Bradley E A, Bradley D, Bartley G B. Evaluating health-related quality of life in ophthalmic disease: practical considerations. Arch Ophthalmol 2006; 124: 121–122
  • Tu J V, Willison D J, Silver F L, et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 2004; 350: 1414–1421
  • Armstrong D, Kline-Rogers E, Jani S M, et al. Potential impact of the HIPAA privacy rule on data collection in a registry of patients with acute coronary syndrome. Arch Intern Med 2005; 165: 1125–1129
  • van Wersch A, Eccles M. Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme. Qual Health Care 2001; 10: 10–16
  • McIver S. Preparation and training: the key to better patient involvement. Qual Health Care 2001; 10: 3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.